These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2864572)

  • 21. HLA antigens in mucocutaneous lymph node syndrome in New England.
    Krensky AM; Berenberg W; Shanley K; Yunis EJ
    Pediatrics; 1981 May; 67(5):741-3. PubMed ID: 7255009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Factors in the development of Kawasaki disease and specificity of immunity in children].
    Matsuoka Y; Yata J
    Nihon Rinsho; 1983 Sep; 41(9):2047-51. PubMed ID: 6363750
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mucocutaneous lymph node syndrome (Kawasaki disease). Presentation of 3 cases].
    Hernández Lorca A; Bentiez Rubio MR; García Santiago M; Hernández Delgado J; García Suárez E; González Mediero I; Silgo Pujalte M; García Pérez J
    An Esp Pediatr; 1983 Jul; 19(1):59-64. PubMed ID: 6638713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kawasaki disease.
    Samuel J; O'Sullivan J
    Br J Hosp Med; 1996 Jan 17-Feb 6; 55(1-2):9-14. PubMed ID: 8646401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mononuclear cell subsets and coronary artery lesions in Kawasaki disease.
    Furukawa S; Matsubara T; Yabuta K
    Arch Dis Child; 1992 Jun; 67(6):706-8. PubMed ID: 1378258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kawasaki disease: association with uveitis in seven patients.
    Lapointe N; Chad Z; Lacroix J; Jacob JL; Urbanski P; Polomeno R; Kupfert B; Courtecuisse V; Décary F
    Pediatrics; 1982 Mar; 69(3):376-8. PubMed ID: 7063297
    [No Abstract]   [Full Text] [Related]  

  • 27. [Properties of protective antigen isolated from Coxiella burneti (author's transl)].
    Schramek S; Brezina R
    Cesk Epidemiol Mikrobiol Imunol; 1974 Dec; 23(6):321-5. PubMed ID: 4281352
    [No Abstract]   [Full Text] [Related]  

  • 28. Soluble CD2 levels in serum during acute Kawasaki disease and infectious mononucleosis.
    Furukawa S; Matsubara T; Obara T; Okumura K; Yabuta K
    J Infect Dis; 1993 Mar; 167(3):778-9. PubMed ID: 8095062
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study on peripheral blood mononuclear cell subpopulations in children. Part II. Peripheral blood mononuclear cell subpopulations in patients with Kawasaki disease].
    Ogiwara A
    Arerugi; 1984 Jul; 33(7):369-75. PubMed ID: 6497666
    [No Abstract]   [Full Text] [Related]  

  • 30. [Complement system in immunological disease of infants and children. Part 1. The role of the complement system in Kawasaki disease].
    Kaneda Y
    Arerugi; 1983 Jul; 32(7):376-85. PubMed ID: 6639368
    [No Abstract]   [Full Text] [Related]  

  • 31. [Gamma globulins and Kawasaki disease].
    Musumeci S; Fischer A; Di Dio R
    Pediatrie; 1986 Jun; 41(4):333-5. PubMed ID: 2433677
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunological abnormalities in Kawasaki disease.
    Okumura K; Jujho K; Yanase Y
    Prog Clin Biol Res; 1987; 250():167-74. PubMed ID: 3423036
    [No Abstract]   [Full Text] [Related]  

  • 33. [Complement fixing antibodies against Coxiella burneti in a sample of the population of Accra (Ghana)].
    Russo V; D'Arrigo C
    Ann Med Nav (Roma); 1968; 73(5):431-6. PubMed ID: 5743217
    [No Abstract]   [Full Text] [Related]  

  • 34. [A study of immune complexes in Kawasaki disease].
    Yanase Y; Kawasaki T; Yoshinoya S; Aikawa T; Hashimoto Y; Mitamura T; Miyoshi Y; Muranaka M; Miyamoto T
    Arerugi; 1984 Jan; 33(1):59-65. PubMed ID: 6743029
    [No Abstract]   [Full Text] [Related]  

  • 35. The immunopathogenesis and management of Kawasaki syndrome.
    Leung DY; Schlievert PM; Meissner HC
    Arthritis Rheum; 1998 Sep; 41(9):1538-47. PubMed ID: 9751085
    [No Abstract]   [Full Text] [Related]  

  • 36. Mucocutaneous lymph-node syndrome (Kawasaki disease): probable soluble-complex disorder.
    Fossard C; Thompson RA
    Br Med J; 1977 Apr; 1(6065):883. PubMed ID: 139964
    [No Abstract]   [Full Text] [Related]  

  • 37. [The levels and relationship of anticardiolipin antibody and anti-beta 2-glycoprotein I antibody in the serum of children with Kawasaki disease].
    Liu GY; Tan Y; Du JB
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):214-5. PubMed ID: 15833202
    [No Abstract]   [Full Text] [Related]  

  • 38. [Imbalance among circulating T cell subsets and staining for HLA-DR antigen in coronary endothelial cells in Kawasaki disease].
    Terai M; Kohno Y; Niwa K; Umemiya T; Mikata A; Nakajima H
    Arerugi; 1987 Jul; 36(7):394-403. PubMed ID: 3500695
    [No Abstract]   [Full Text] [Related]  

  • 39. Circulating immune complexes in mucocutaneous lymph-node syndrome (Kawasaki disease).
    Weindling AM; Levinsky RJ; Marshall WC; Hood J
    Arch Dis Child; 1979 Mar; 54(3):241-2. PubMed ID: 434916
    [No Abstract]   [Full Text] [Related]  

  • 40. Epstein-Barr virus-specific cytotoxic T lymphocyte (EBV-CTL) activities in patients with Kawasaki syndrome.
    Shinohara K; Katsuki T; Koike M
    Prog Clin Biol Res; 1987; 250():569-70. PubMed ID: 2827182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.